Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs
Mood disorders are prevalent and disabling. They are highly co-morbid with other psychiatric disorders. Currently, there are no objective measures, such as blood tests, used in clinical practice. The development of blood tests would make a significant difference at an individual and societal level

Related Post